During the first two to four weeks, participants in trials have reported: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort are among the most commonly reported side effects
Rougraff BT, Aboulafia A, Biermann JS, Healey J
For researchers chasing groundbreaking discoveries, having a high-quality, reliable peptide is a game-changer
Semin Cutan Med Surg (2009) 28:15764
Some individuals report improvement in chronic conditions, while others note rashes or nonspecific irritation
For people who cant tolerate injections or who strongly prefer oral medication, Rybelsus remains a reasonable option for managing type 2 diabetes